Endometriosis. The case for early, aggressive treatment

Area of Science:

• Gynecology
• Immunology
• Metabolic Science

Background:

• Endometriosis pathophysiology involves complex metabolic and immunologic changes.
• Clinical management decisions for endometriosis require consideration of these factors.
• Understanding disease progression, recurrence, and treatment effects is crucial.

Purpose of the Study:

• To review literature on endometriosis, focusing on immunologic aspects.
• To propose innovative management strategies for early-stage endometriosis.
• To provide guidance for clinicians treating endometriosis.

Main Methods:

• Literature review of immunologic aspects of endometriosis.
• Analysis of data on nonclassic, early, and deep endometriosis.
• Examination of disease progression, recurrence, and treatment effects.

Main Results:

• Immunologic factors play a significant role in endometriosis.
• Early-stage endometriosis requires aggressive management.
• Adjunct medical treatment is recommended post-surgery.

Conclusions:

• Aggressive treatment of symptomatic early-stage endometriosis is warranted.
• Gonadotropin-releasing hormone agonist therapy is a strong consideration after surgical resection.
• Innovations in managing early-stage endometriosis are proposed.